Healthcare Market Research Report: March 2017

Wednesday, 15 March 2017

Osteoporosis Drugs Market - Global Industry Analysis, Pipeline Analysis, Size, Share, Growth, Trends & Forecast 2020

Transparency Market Research Report Added “Osteoporosis Drugs Market (By Drug Class Bisphosphonates, Calcitonin, RANK Ligand Inhibitors, Parathyroid Hormone Therapy (PTH), Selective Estrogen Receptor Modulators (SERMs), Others Estrogen therapy and vitamin D and Calcium) " to its database.

Osteoporosis Drugs Market: Discription

Osteoporosis is a chronic and life-threatening disease, in which microstructure of bones is altered due to reduction in bone mass and bone density. This condition leads to increased bone fragility and threat of bone cracks and fractures. Thus, osteoporosis is considered life threatening due to severe injury and associated pain. The osteoporosis drugs market report studies the current scenario as well as the future market potential for osteoporosis drugs globally. The disease overview section of the report provides a brief introduction of osteoporosis along with causes, diagnosis, symptoms and management methodology. The market for osteoporosis drugs has been segmented on the basis of drug classes used to treat the disease. The market for these drug classes has been extensively analyzed on the basis of factors such as therapeutic application, geographic presence, pipeline drug candidates, patents and global impact on sales of the drugs (along with the class) after patent expiry. Based on drug class, the market is divided into bisphosphonates, calcitonin, RANK Ligand Inhibitors (denosumab), parathyroid hormone therapy (PTH), selective estrogen receptor modulators (SERMs) and others (estrogen therapy and vitamin D - calcium). Bisphosphonates is the largest and established drug class. However, the entire class is driven by generic products. Hence, market share of this class is expected to decrease during the forecast period from 2014 to 2020. In addition, new drug classes such as RANK Ligand Inhibitors and PTH are considered as important contributors in the market. Pipeline products such as odanacatib (cathepsin K inhibitor) and romosozumab are also forecasted from the expected year of approval. The market size and forecasts in terms of revenue (USD million) for each of these segments have been provided for the period 2012 to 2020, considering 2013 as the base year. The report also provides the compounded annual growth rate (CAGR) for each segment of the market for the forecast period 2014 to 2020.

Browse Market Research Report:
http://www.transparencymarketresearch.com/osteoporosis-drug-market.html

Osteoporosis Drugs Market: Overview

Geographically, the osteoporosis drugs market is segmented as North America, Europe, Asia-Pacific and Rest of the World (RoW). Presently, the North American region is the largest market in the world, owing to the presence of large number of osteoporosis patients, world-class medical infrastructure, rising awareness about the disease and its treatment and proper utilization of technologically sound devices for diagnosis purpose. However, Asia-Pacific region is considered as the most promising market during the forecast period from 2014 to 2020. The growth is mainly attributed to factors such as steadily increasing incidence rate of osteoporosis, increasing medical expenditure, increased healthcare awareness towards diagnosis and treatment of osteoporosis and dietary habits and lack of nutritious foods.

Fill the form for an exclusive sample of this report:

http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=133

The osteoporosis drugs market is considered as semi-consolidated and is dominated by selective players. More than 63% of the total market share is held by market players such as, Eli Lilly and Company, Pfizer, Inc., Amgen, Inc., Merck & Co., Inc. and Novartis International AG. These players, due to their effective products, dominate the entire market. In addition, other players include F. Hoffmann La Roche Ltd., Actavis plc, Teva Pharmaceutical Industries Ltd. and Novo Nordisk A/S. which contributed to the market with their generic formulations.

Contact

Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
Browse market research blog: https://tmrresearch.blogspot.com/

Latin America Home Healthcare Market is Expected to Reach US$ 17.55 Billion by 2020

Transparency Market Research Report Added “Latin America Home Healthcare Market (By Device Types: Diagnostics and Monitoring Devices, Therapeutic Home Healthcare Devices, Mobility Assist Devices and Medical Supplies; By Services: Rehabilitation, Telehealth and Telemedicine, Respiratory Therapy, Infusion Therapy and Unskilled Home Healthcare Services) " to its database.

Latin America Home Healthcare Market: Discription

Home healthcare devices and services help the patients to be self-sufficient towards their health. This is been increasingly accepted by the patient population owing to its cost effective nature, less number of visits to hospital and patient comfort. The Latin America home healthcare market has witnessed significant growth in the past due to factors such as increasing number of patients diagnosed with chronic diseases like diabetes, cardiac disorders, respiratory diseases and others. At the same time, economic instability and reimbursement issues related to home healthcare services are the factors restraining the market growth during the forecast period from 2014 to 2020.

Browse Market Research Report:
http://www.transparencymarketresearch.com/latin-america-home-healthcare-market.html

This report provides an in-depth and comprehensive analysis of the Latin America home healthcare market on the basis of device types, services and the major Latin American geographies. In device types segment, the report covers different types of diagnostic and monitoring devices, therapeutic devices, medical supplies and home mobility assist devices that are used by the patients. Diagnostics and monitoring devices segment includes devices such as blood glucose monitors, blood pressure monitors, sleep apnea monitors, pregnancy test kits, pulse oximeters, heart rate monitors, temperature monitors, pedometers and coagulation monitors. Therapeutic devices segment comprises insulin delivery devices, nebulizers, ventilators and CPAP devices, IV equipment and dialysis equipment. The home mobility assist devices segment is further categorized as wheelchairs, cranes and crutches and other mobility assist devices and medical supplies segment includes feeding tubes and syringes. The market size and forecast for each device type has been provided for the period 2012 to 2020, considering 2013 as the base year. The report also provides the compounded annual growth rate (% CAGR) for the forecast period 2014 to 2020 for each segment.

Latin America Home Healthcare Market: Overview

Home healthcare represents use of medical devices and community based services to support patients suffering from chronic diseases. Currently, the home healthcare market is moving towards a precision-based model of personal care. Home-based medical devices and services play an important role in providing personal care to patients in managing variety of disease conditions such as diabetes, chronic obstructive pulmonary disease and blood pressure. Increasing patient population with chronic diseases such as diabetes, blood pressure, cardiovascular conditions and respiratory diseases globally (including Latin America) would drive the demand for home-based medical devices and services. These diseases require continuous monitoring, and thus involve high cost due to repeated visits to healthcare centers that inflate medical expenses. Thus, home healthcare devices and services are being rapidly adopted by consumers to measure parameters on a regular basis and to cut down medical costs. The Latin America home healthcare market is estimated to be USD 9,796.8 million in 2013 and is expected to reach USD 17,550.0 million by 2020, growing at a CAGR of 8.7% from 2014 to 2020.

Fill the form for an exclusive sample of this report:
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=3020

Latin America home healthcare market is mainly segmented into device types and services. Latin America home healthcare device segment is considered to be the largest segment and is estimated to grow at the highest CAGR during the forecast period from 2014 to 2020. This growth was mainly attributed to high acceptance of medical devices coupled with technological advancements (introduction of automated and portable devices) to fuel the growth of the home healthcare devices market in Latin America. The market of ventilators and CPAP devices segment is estimated to grow at the highest CAGR of 11.4% from 2014 to 2020. The mobility assist devices segment is further categorized into wheelchairs, cranes and crutches and other home mobility assist devices.

Contact

Intrathecal Pumps Market Analysis by Product Type & Applications, Emerging Trends, Size, Share, Supply Chain and Analysis up to 2020

Transparency Market Research Report Added “Intrathecal Pumps Market (Pain and Spasticity Management, Payer Breakdown for Reimbursement and Drugs in Intrathecal Pumps) " to its database.

Intrathecal Pumps Market: Discription

The report on intrathecal pumps market analyzes the current as well as future prospects and various facets of the market in detail. Intrathecal infusion pumps are used to deliver therapeutic doses of drugs for pain and spasticity, into a patient’s body, particular in the spine at a precisely controlled rate. The global intrathecal pumps market has witnessed significant growth in the past due to worldwide increase in number of patients with chronic pain and cancer pain. This report provides an in-depth and comprehensive analysis of the global intrathecal pumps market. The research covers current as well as future prospects of the market globally. It includes an exhaustive executive summary, which covers a market snapshot that provides information of various segments such as applications (pain and spasticity) and geography (North America, Europe, Asia-Pacific and Rest of the World).

Browse Market Research Report:
http://www.transparencymarketresearch.com/intrathecal-pumps-market.html

For the research on this topic, we conducted in-depth interviews and discussions with a wide range of key opinion leaders within intrathecal pumps market, which was supplemented by extensive secondary research. The market assessment and forecast in terms of revenue (USD million) and number of procedures for each segment of intrathecal pumps market have been provided for the period 2012 to 2020, considering 2013 as the base year. The report also provides the compounded annual growth rate (CAGR %) for the global intrathecal pumps market and each sub-segment, for the forecast period 2014 to 2020. Growth rates for each segment within the global intrathecal pumps market have been determined after thorough analysis of past trends, demographics, future trends, technological developments, regulatory requirements.

Intrathecal Pumps Market: Overview

Intrathecal pump is a surgically implanted system used to infuse potent medication directly into or around the spinal cord. These pumps are typically intended for use in chronic pain and spasticity management for delivering potent medicines in the intrathecal space which allows administration of drugs in very low doses. This significantly reduces the side effects associated with the drugs. The global intrathecal pumps market was valued at USD 199.8 million in 2013, and is expected to grow at a CAGR of 4.1% to reach an estimated value of 264.8 million by 2020.

Fill the form for an exclusive sample of this report:
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1599

The global intrathecal pumps market is witnessing healthy growth amidst the frequent product recalls. Driving factor for the market growth is the device’s ability to reduce debilitating pain and drug administration in low doses. This benefits patients with lesser side effects and more rapid therapeutic effects compared to other forms of medication. Chronic pain affecting approximately 20% to 30% of the U.S. population is the largest driver for intrathecal pumps. The prevalence of chronic pain is also severe in other parts of the world. In 2013, the market for these pumps was largely driven by demand for treating chronic pain and this application alone contributed to more than two-third of the total market revenue. The pain management application is expected to maintain its top position during the forecast period from 2014 to 2020 due to large untapped patient base and wider side effects of existing opioid analgesics administered via routes other than intrathecal.

Contact

Disinfectors Market (By Application Hospitals and Clinics, Pharmaceuticals and Elder Care) - Latest Innovations, Drivers, Restraints, Challenges and Forecast 2020

Transparency Market Research Report Added “Disinfectors Market (By Product Type Washer, Flusher and Endoscope Reprocessors By Application Hospitals and Clinics, Pharmaceuticals and Elder Care) " to its database.

Disinfectors Market: Discription

Disinfection is an essential procedure that is performed for infection control in healthcare facilities such as hospitals, clinics, elder care institutes and laboratories, using disinfectors and other infection control equipment such as sterilizers. Medical instruments, bedpans and urine bottles are placed inside the washers and flusher for disinfecting. The market is anticipated to grow with increasing number of hospital-acquired infections that has compelled medical professionals to use disinfectors. In addition, increase in the number of surgeries performed at hospitals and clinics and rising geriatric population will further propel the growth of disinfectors market. This is due to the fact that elderly people are more prone to various diseases that increase their hospital visit and uptake of various medical services. Hence, owing to the above mentioned facts the demand for disinfectors is expected to grow.

Browse Market Research Report:
http://www.transparencymarketresearch.com/disinfectors-market.html

The global disinfectors market, based on product type has been segmented as washer disinfectors, flusher disinfectors and endoscope reprocessors. The market for washer disinfectors has been further segmented as single chamber and multi-chamber washer disinfectors. Single chamber washer disinfectors market has been further segmented as single door and double door. The market for these products has been extensively analyzed based on number of installed base, efficiency, application area and cost. The market size and forecast in terms of USD million for each product type has been provided for the period 2012 to 2020, considering 2013 as the base year. The report also provides compounded annual growth rate (% CAGR) for the forecast period 2014 to 2020 for each segment.

Disinfectors Market: Overview

Disinfection ensures usage of pathogen free medical instruments such as endoscopes, surgical instruments and bedpans. Disinfection is a process of destroying pathogenic organisms and is achieved with the usage of various equipment and consumables such as disinfectants, detergents and disinfectors. Disinfectors represent a class of equipment used for cleaning medical devices, ensuring hygiene of the instruments. The market - witnessed -a tremendous growth rate of 10.2% from 2014 to 2020 owing to increasing number of hospital-acquired infections (HAI). HAI occur due to the usage of improperly cleaned medical instruments. In order to reduce such incidences, the demand for disinfectors is anticipated to grow during the forecast period. Similarly, increasing number of surgeries in hospitals and clinics would also propel the growth of this market as for disinfecting medical devices (used in surgeries) and disinfectors are utilized. Likewise, increasing disposable income in developing countries will further augment the growth of the market as it would assist in increasing the affordability for availing medical services that require medical instruments and hence, disinfectors market would also grow. Moreover, increasing number of elder care institutions across the globe is likely to accentuate the growth of flusher disinfector and -the overall disinfectors market. Considering the above mentioned factors, the market for disinfectors is expected to grow at a CAGR of 10.2% from 2014 to 2020 to reach an estimated value of USD 3,116.5 million in 2020.

Fill the form for an exclusive sample of this report:
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2947

The market for disinfectors has been segmented on the basis of product type such as washer disinfectors, flusher disinfectors and endoscope reprocessors. The market for endoscope reprocessors and washer disinfectors accounts for the largest share throughout the forecast period. The growth of these segments is expected to be impressive from 2014 to 2020 owing to increasing usage of endoscopes and medical instruments due to rising incidences of various diseases such as cancer, cardiovascular diseases and others. The market is also expected to accentuate due to increasing number of hospitals across the globe.

Contact

Global Dialysis Products and Services Market to Reach US$115.4 bn by 2020, Increasing Prevalence of Kidney Diseases Drives Growth

Transparency Market Research Report Added “Dialysis Products and Services Market (Hemodialysis Products, Peritoneal Dialysis Products; In-center Dialysis Services and Home Dialysis Services) " to its database.

Dialysis Products and Services Market: Discription

Dialysis is a life-sustaining process that purifies the blood of kidney failure patient by cleaning waste products, removing extra fluids and by controlling the body’s fluidic levels. Dialysis products and services market would be experiencing impressive growth majorly due to rising prevalence of chronic kidney diseases (CKD) and rapidly rising diabetic population.

This report studies the global market for dialysis products and services from three major perspectives: product type, service type and geography. The stakeholders of this study include existing companies manufacturing dialysis products or providing dialysis services to the patients and new entrants who are planning to invest in this market. The report comprises of an executive summary section that provides a snapshot of the market with succinct information about market size and growth of different product segments, services, market share and geographic analysis of the global dialysis products and services market.

Browse Market Research Report:
http://www.transparencymarketresearch.com/dialysis-products-services-market.html

The market overview section illustrates about the global market dynamics and trends comprising of drivers, restraints and opportunities that influence the current and future status of the dialysis products and services market. Several other factors such as market share analysis by major market players and Porter’s five force analysis are also included in this report providing a thorough analysis about the competitive scenario in the global dialysis products and services market. Further, the market overview section also includes regulatory scenario of dialysis products and services market at global scale along with the announcements and guidelines by important bodies such as Food and Drug Administration (FDA) and Association for the Advancement of Medical Instrumentation (AAMI). These factors are explained thoroughly to help the market players in planning their strategies which will help them in expanding their presence and in strengthening their position in the global market.

Dialysis Products and Services Market: Overview

According to the National Institutes of Health, the worldwide number of patients with chronic kidney disease is rising rapidly and is expected to rise by approximately 5% to 8% annually. Increasing prevalence of diabetes and hypertension are the two primary causes of end stage renal disease in major developing countries like China, Brazil and India and is also contributing to the growth of overall dialysis products and services market. According to the American Kidney Fund, diabetes and hypertension are responsible for 38.4% and 25% of all cases of kidney failures, respectively. Similarly, increasing geriatric population and low preference by patients above 65 years of age to opt for kidney transplant is also driving the growth of dialysis products and services market. According to the Australian Institute of Health and Welfare, the proportion of people opting for kidney transplantation decreases with age. Moreover, increasing awareness about peritoneal dialysis is expected to boost the growth of the market in the near future.

Fill the form for an exclusive sample of this report:
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=3026

The global dialysis products and services market is segmented by type of procedures and type of services. The procedures market is further segmented into hemodialysis and peritoneal dialysis. Further, the hemodialysis segment (HD) is classified into HD machine, dialyzer, access products/catheters, bloodlines, concentrates and others, which include water treatment systems and fistula needles. Hemodialysis, being the oldest and most preferred technique for dialysis procedure, Hemodialysis machines captures the largest share, of the total market in 2013. The segment is expected to lead the market during the forecast period from 2014 to 2020. Similarly, peritoneal dialysis (PD) segment is classified into concentrates/dialysate, PD machines, catheters, and transfer sets. Among these, the PD concentrates/dialysate segment is accounted for largest market share in 2013 and is expected to grow at an attractive higher growth rate during the forecast period from 2014 to 2020. The major factors responsible for the significant growth of this segment are increase in the number of patients preferring peritoneal dialysis, and rising demand of patients to be dialyzed overnight with the aid of peritoneal dialysis.

Contact

Cell Culture Protein Surface Coatings Market: An Overview of Growth Prospects and Market Restraints

Transparency Market Research Report Added “ACell Culture Protein Surface Coatings Market (Plant source, animal source, human source, synthetic source, self-coating and pre-coating (multiwall/microwell plates, petri dishes, flasks, slides and cover slips) " to its database.

Cell Culture Protein Surface Coatings Market: Discription

Cell culture is a complex procedure that involves growth of cells outside the natural environment by controlling the nutritional requirements and physical factors such as temperature and humidity required for proper growth. The cultured cells are used for the analysis of cellular structures and functions, developing model systems for research, genetic and molecular engineering, stem cell research and drug discovery. Additionally, cell culturing is performed for commercial production of drugs and biologics including vaccines, antibodies and proteins. All these procedures require protein coating for proper growth and differentiation of cell samples. Increase in the number of applications and cell related research and development activities are the major factors driving the cell culture protein surface coatings market.

Browse Market Research Report:
http://www.transparencymarketresearch.com/cell-culture-protein-surface-coatings-market.html

This report studies the global market for cell culture protein surface coating products through three major perspectives: protein source, type of coating and geography. The stakeholders of this report include the companies involved in the production of cell culture protein surface coating materials and coated labware and new players who wish to enter the market. The executive summary provides an overview of market size and growth of different product segments, market share and geographic analysis of the global cell culture protein surface coatings market.

Cell Culture Protein Surface Coatings Market: Overview

Cell culture is a complex procedure in which cells are grown under controlled physical conditions outside the natural environment. These cells are used to develop model systems for research, study of cellular structure and functions, stem cell research, drug discovery and genetic engineering. Growing scope of cell culture and its applications has led to increased use of protein coated surfaces, as these provide better adhesion and proper nutrition for growth of the cells during cell culture.

Fill the form for an exclusive sample of this report:
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2993

Rising investment by government and market players in stem cell research and development activities is one of the major factors driving the cell culture protein surface coatings market. Becton, Dickinson and Company grants a total of USD 100,000 worth reagents every year to 10 scientists pursuing research activities in stem cells. Similarly, the European Union funded four stem cell research projects in its Seventh Framework Program for Research and Technological Development (2007 - 2013). High funding is leading to extensive stem cell research, resulting in increased use of cell culture protein surface coating products. Moreover, diverse applications of stem cells such as development of bone grafts and artificial tissue would fuel the demand for cell culture protein surface coatings during the forecast period. In addition, increasing cell culture applications in toxicology studies and cell-based assays would boost the demand for protein surface coating products. Currently, 2D cell culture is the most preferred technique by researchers worldwide due to lack of compelling data to switch to 3D cell culture.

Contact

Array Instruments Market: Applications and Global Markets

Transparency Market Research Report Added “Array Instruments Market (Technologies DNA Microarrays, Protein Microarrays, Cellular Microarrays, Tissue Microarrays End Users Research and Development Laboratories, Clinical Diagnostic Labs, Agriculture Research Centers, Forensic Centers, Veterinary Laboratories) " to its database.

Array Instruments Market: Discription

This report on the array instruments market studies the current as well as future prospects of the market globally. Microarray technology though a traditional bio technological tool, is gaining a rapidly evolving and emerging technology. Microarrays concept and methodology was first introduced in 1983 by Tse Wen Chang in a scientific publication. The microarray industry grew significantly after the 1995 Science Paper by the Ron Davis and Pat Brown labs at Stanford University. The technology of DNA microarrays has become the most sophisticated and the most widely used, with the establishment of companies such as Affymetrix, Inc., Agilent Technologies, Illumina, Inc., ArrayIt Corporation and others, while the use of protein, peptide, cells, tissue and carbohydrate microarrays are expanding. The technology is used to detect, assess and analyze the interaction between different molecules such as DNA, RNA, proteins, siRNA, pharmaceuticals, carbohydrates, and antibodies. This report includes an elaborate executive summary, which covers a market snapshot that provides overall information of various segments that are contained in the report. It also provides an overall information and data analysis of the global array instruments market with respect to market segments based on technology, end users as well as geographic regions.

Browse Market Research Report:
http://www.transparencymarketresearch.com/global-array-market.html

The array instruments market is segmented based on major technologies into four categories: DNA microarrays, protein microarrays, cellular microarrays and tissue microarrays. The market for these microarray technologies has been extensively analyzed based on usefulness, effectiveness, sales revenue of the instruments based on the technologies and geographic presence. The market size and forecast in terms of USD million for each technology type and end user segment has been provided for the period 2012 to 2020. The report on the array instruments market also provides % compounded annual growth rate (CAGR) for each market segment for the forecast period 2014 to 2020, considering 2012 and 2013 as the base year.

Array Instruments Market: Overview

Microarray is a collection of microscopic spots of DNA, RNA, oligonucleotides, proteins, peptides, cells, tissues and other compounds which are attached to a solid substrate. Other microarray platforms include use of microscopic beads. With the help of array instruments, these microarrays are used to measure gene expression levels simultaneously in a single reaction and also genotype multiple regions of genome. The global array instruments market is driven by the large number of patients awaiting diagnosis of the exact type of cancer, metabolic diseases, and post natal diseases along with the research on the causes and treatment for such diseases. Disease diagnosis and detection has been the most critical and beneficial microarray application for the diagnosis and prognosis of different types of diseases, majorly cancer.

Fill the form for an exclusive sample of this report:

http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=495

At present, a broad range of microarray technologies are available in the market for research purpose. DNA microarray is the most traditional and widely accepted technology in the microarray field. Thus, it accounts for the largest share, in the total market, owing to improved accuracy and precision and wide acceptance by the end users. The advent of DNA microarray has accelerated the process of gene expression, disease diagnosis, drug discovery and SNP analysis. Protein microarray which is the second largest and the fastest growing technology is very effective in identifying protein-protein interactions, substrates of protein kinases and activities of proteins. Due to high throughput, high resolution and sensitivity, protein microarray is extensively used in proteomics for protein expression profiling. Gene expression is the largest application market followed by the drug discovery and diagnosis market. High cost associated with the instruments and need for expertise leads to decreased adoption of microarray technology, particularly in developing countries. Moreover, increase in awareness for disease diagnosis and introduction of cheaper instruments and reagents will together aid in maintaining the growing of microarray technologies.

Contact

Acute Ischemic Stroke Diagnosis and Treatment Market: Applications and Global Markets

Transparency Market Research Report Added “Acute Ischemic Stroke Diagnosis and Treatment Market (By Diagnostics Type - CT, MRI, Ultrasound, Cerebral Angiography, Nuclear Imaging and Others By Surgery Type - Carotid Endarterectomy, Angioplasty and Endovascular Mechanical Thrombectomy) " to its database.

Acute Ischemic Stroke Diagnosis and Treatment Market: Discription

Acute ischemic stroke can be defined as interruption of blood supply to the brain due to the blockage of blood vessel due to atherosclerosis plaques or blood clots in the artery. Acute ischemic stroke can caused due to thrombotic or embolic occlusion of cerebral artery. This research report on acute ischemia diagnosis and treatment market explains various advancements occurring in this market and analyzes the global acute ischemic stroke diagnosis and treatment market by diagnosis types and surgery types as well as geographic regions. This report comprises of an elaborate executive summary, which includes a market snapshot that provides a market dynamics of various segments and sub-segments that are included in the report in a precise manner. Moreover, executive summary comprises waterfall diagram which is drawn that reflects the market size of various segments in descending order.

Browse Market Research Report:
http://www.transparencymarketresearch.com/acute-ischemic-stroke-treatment.html

The global market for acute ischemic stroke diagnosis and treatment is segmented based on diagnosis such as Computed Tomography (CT), Magnetic Resonance Imaging (MRI), ultrasound, cerebral angiography, nuclear imaging and others. The market for these diagnosis types has been extensively analyzed based on consistency, effectiveness and sales revenue of the product developed by the manufacturers. The market size and forecast in terms of USD million for each diagnosis type has been provided for the period 2012 to 2020. The report on the acute ischemic stroke diagnosis and treatment market also provides % compounded annual growth rate (CAGR) for each of the aforementioned market segment for the forecast period 2014 to 2020, considering 2013 as the base year.

Acute Ischemic Stroke Diagnosis and Treatment Market: Overview

Acute ischemic stroke can be defined as loss of function in certain parts of brain due to lack or disturbance in the blood supply to the brain. This is usually caused by atherosclerosis plaques blocking blood vessels, narrowing of blood vessels, or blood clots closing off blood supply to or from arteries feeding the brain. Technological advancements in surgical devices coupled with rising prevalence of acute ischemia stroke cases collectively accentuates the global demand of surgical procedures in acute stroke treatment. Similarly, aging population, increased demand for minimally invasive procedures and rise in healthcare spending has triggered the growth of this segment market. However, excessive usage of medication for the treatment of ischemic stroke is anticipated to hinder the global market growth of surgery for acute stroke. The global acute ischemic stroke diagnosis and treatment market was valued at USD 1,225.0 million in 2013 and is expected to grow at a CAGR of 6.3% from 2014 to 2020, to reach an estimated value of USD 1,869.7 million by 2020.

Fill the form for an exclusive sample of this report:
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1799

The global market for acute ischemic stroke diagnosis and treatment is segmented based on diagnostics type as CT, MRI, ultrasound, cerebral angiography, nuclear imaging and others. In 2013, CT segment accounted for the largest market share of the global acute ischemic stroke diagnosis and treatment market owing to efficient and effective detection, easy availability and strong demand of CT in the global market. Moreover, MRI is expected to grow at the highest CAGR compared with all diagnostic device types during the forecast period due to its increasing popularity.

Contact

Tuesday, 14 March 2017

Immunoassay Instruments Market: Technologies and Global Markets

Transparency Market Research Report Added “AImmunoassay Instruments Market (Product Chemiluminescence (CLI), Immunofluorescence (IFA) & Radioimmunoassay (RIA) Analyzers, Enzyme Linked Fluorescence (ELFA) & Multiplexed Assay Systems, Enzyme Immunoassay Instruments Application Oncology, Endocrinology, Infectious Diseases, Therapeutic Drug Monitoring, Cardiology, Autoimmune Disorders & Drugs of Abuse) " to its database.

Immunoassay Instruments Market: Discription

Immunoassay is a laboratory-based diagnostic procedure performed using an immunological reaction of antibodies. Immunoassay instruments measure the formation of antibody-antigen complexes in blood samples or other body fluids and are commonly employed to detect analytes in qualitative (positive/negative) or quantitative manner. An example of qualitative analysis of immunoassay test include immunoassay test for pregnancy by detecting human chorionic gonadotropin (hCG) in urine samples. Immunoassay tests now-a-days are exploring new avenues of applications in diagnosing infectious diseases, toxicology testing, detection of cancer biomarkers and other drug monitoring tests. Immunoassay techniques are especially suited for analyzing compounds that are present in extremely low concentration (nanogram to picogram) and without any prior treatments to enhance its detection.

Several common technologies that are employed by immunoassays include enzyme-linked immunosorbent assay (ELISA), immunofluorescence, radioimmunoassay, chemiluminescent immunoassay, enzyme linked fluorescence and other similar techniques. Global immunoassay instruments market is analyzed on the basis of products and application. The product market is sub-segmented into six major categories namely Chemiluminescence (CLI) Analyzers, Immuno Fluorescence (IFA) Analyzers, Enzyme Immunoassay Instruments, Radioimmunoassay (RIA) Analyzers, Enzyme Linked Fluorescence (ELFA) Analyzers and Multiplexed Assay Systems.

Browse Market Research Report:
http://www.transparencymarketresearch.com/immunoassay-instruments-market.html

Immunoassay Instruments Market: Overview

Immunoassay instruments market is witnessing a rapid technological growth that has resulted in significant market opportunity for efficient bioanalytical platforms. Currently, market players are engaged in developing immunoassay platforms with enhanced capabilities such as broad menu of tests, higher sensitivity and specificity. Other major advances introduced to researchers include shorter turnaround times (TAT), higher productivity and easy operation thereby ensuring efficient detection and determination with accurate results. The market is witnessing significant advances in the design of immunoassay platforms shifting from conventional non-competitive assays to competitive assays that are permitting the efficient detection of small molecules such as drug pollutants and metabolites. For instance, introduction of ADVIA Centaur CP Immunoassay System by Siemens Healthcare, a mid-sized immunoassay system that provides a broad menu of tests and enhanced workflow which enables overall cost reduction and eliminate the need for multiple systems.

Although, the use of immunoassay platforms has been confined to hospitals and reference laboratories, currently, there is an increasing preference for commercial diagnostic laboratories owing to their special care and short turnaround times as compared to hospitals. Tier-1 diagnostic laboratories are currently focusing on expanding their operations in less developed areas by acquiring Tier - 2 and Tier – 3 laboratories with minimal infrastructure. This creates a strong demand for compact and portable assay platforms with high reliability and sensitivity. In addition, these platforms can run on batteries in case of power failure and can be moved in ambulances in case of emergency requirements. All these features along with high affordability are expected to provide impressive growth opportunities for immunoassay instruments market.

Fill the form for an exclusive sample of this report:
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1635

Contact